Sat, Dec 20, 2014, 6:44 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • colby.bull colby.bull Dec 1, 2010 5:23 PM Flag

    AND. more good news

    Tampa International Airport executive resigns amid conflict of interest inquiry
    Agricultural research employee killed in wreck north of Brooksville
    Jon Gruden just what University of Miami needs in a coach
    Health
    Briefs: As weight soars, so does risk of death
    Tours available for electrophysiology lab at Hudson hospital
    HCA trauma plan reveals politics behind lifesaving service
    Flexible spending accounts to require prescriptions for over-the-counter drugs
    Briefs: Study finds that low-carb diet can help losers keep weight off
    Briefs: As weight soars, so does risk of death
    In Print: Thursday, December 2, 2010
    Science & Technology


    FDA okays stem cell study on eye patients

    The Food and Drug Administration has approved a request by Advanced Cell Technology to inject cells created from human embryonic stem cells into the eyes of 12 patients suffering from advanced cases of Stargardt's macular dystrophy, which progressively destroys vision, usually beginning in childhood. It is currently incurable. The study will involve injecting 50,000 to 200,000 cells known as retinal pigment epithelial cells in the hopes that they will replace those ravaged by the disease. "I think this marks the beginning of a new era for stem cell research," said Robert Lanza, the company's chief scientific officer.

 
ACTC
6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.